ClinicalTrials.gg
RecruitingNCT07458607Updated Apr 27, 2026

UNC Tobacco Convenience Store

An interventional study of Menthol ban + campaign and Menthol ban in Health Behavior, sponsored by University of North Carolina, Chapel Hill. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,185
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Health Behavior by University of North Carolina, Chapel Hill — 3 open to participants now, 3 under way, none of them phase 3. Health Behavior · University of North Carolina, Chapel Hill.

Planned enrollment
2nd of 10
1,185 · median 384
Started
2026
with 1 other
No phase
10 of 10
3 open now
Registered
10th of 10
by date

Among the 10 studies in Health Behavior by University of North Carolina, Chapel Hill, this one is the 2nd largest by planned enrollment, is one of 2 that started in 2026, is one of 10 with no phase, and was the 10th registered.

Health Behavior

970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.

Browse Health Behavior studies →

Open to participants now

3 of the 10 studies in Health Behavior by University of North Carolina, Chapel Hill are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 94 Health Behavior studies recruiting now, 39 (41%) set no upper age limit and 38 (40%) stop at 75 or younger; 25 take children under 18; 59 take healthy volunteers.

This study: 21 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Health Behavior by University of North Carolina, Chapel Hill, or all of them as a file.
02

Study summary

The main purpose of this trial is to evaluate the impact of a menthol cigarette ban accompanied by a quit smoking campaign on tobacco purchasing behavior. Investigators will conduct a randomized clinical trial with \~1,185 US adults (ages 21+ years) who currently smoke menthol cigarettes.

Read the detailed description

This trial aims to determine whether a quit smoking campaign amplifies the impact of a simulated menthol cigarette ban. The trial will enroll \~1,185 adults ages 21 years and older who currently smoke menthol cigarettes. Participants will attend 2 in-person study visits at our experimental store, spaced approximately 1 week apart. The store will be stocked with a variety of tobacco products, food, non-alcoholic beverages, and household goods. At the first visit, participants will provide written informed consent and will be randomized to 1 of 3 trial arms, described further below. At both study visits, participants will shop for items in the store and complete computer surveys. Researchers will record in-store purchases and other self-reported measures will be assessed via the computer surveys. In between the in-person study visits, participants will receive ads via text message based on their trial arm.

03

Conditions studied

  • Health Behavior

Browse trials for

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Are ages 21 years and older
  • Smoke cigarettes currently (i.e. currently smoke some days or every day and have smoked at least 100 cigarettes in their lifetime)
  • Smoke menthol cigarettes
  • Purchased menthol cigarettes in a store in the past month
  • Read and speak English
  • Can complete a survey on a computer without help
  • Can receive images by text message
  • Can attend 2 in-person appointments involving shopping tasks and computer surveys

Exclusion criteria

Exclusion Criteria:

  • Are pregnant
  • Are breastfeeding
  • Enrolled currently in another research study about quitting smoking
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,185 participants (estimated)

Study arms

  • Experimental
    Menthol ban + campaign

    Behavioral: Menthol ban + campaign

  • Experimental
    Menthol ban

    Behavioral: Menthol ban

  • Other
    Control

    Behavioral: Control

Interventions

  • BehavioralMenthol ban + campaign

    Menthol cigarettes and flavored little cigars and cigarillos will not be available for purchase in the store. Participants will receive quit smoking campaign ads via text message. These ads will also be displayed inside the store during the shopping tasks.

  • BehavioralMenthol ban

    Menthol cigarettes and flavored little cigars and cigarillos will not be available for purchase in the store. Participants will receive control ads about a neutral topic (i.e., password security) via text message. These ads will also be displayed inside the store during the shopping tasks.

  • BehavioralControl

    Menthol cigarettes and flavored little cigars and cigarillos will be available for purchase in the store. Participants will receive control ads about a neutral topic (i.e., password security) via text message. These ads will also be displayed inside the store during the shopping tasks.

06

What researchers measure

Primary outcomes

  1. Purchasing any combustible tobacco products

    Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. Response options are "No" (coded as 0) and "Yes" (coded as 1).

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

Secondary outcomes

  1. Expenditures on combustible tobacco products

    Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. This measure is in US dollars, ranging from $0 to $70.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  2. Purchasing any non-combustible tobacco products (substitution effects)

    Measured using purchase data on whether participants bought any non-combustible tobacco products, defined as any e-cigarettes, smokeless tobacco, or nicotine pouches. Response options are "No" (coded as 0) and "Yes" (coded as 1).

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  3. Attempted to quit smoking

    Measured using 1 survey item: "In the last week, did you stop smoking cigarettes for 1 day or longer because you were trying to quit smoking?" Response options are "No" coded as 0) and "Yes" (coded as 1).

    Time frame: Assessed 1 time, approximately 1 week after enrollment.

  4. Forgoing cigarette use

    Measured using 2 survey items (e.g., " In the last week, how often have you stopped yourself from having a cigarette because you wanted to smoke less?"). The 5-point response scale ranges from "Never" coded as 0, to "10 or more times", coded as 10. Researchers will average responses to the 2 survey items to create a scale score. Higher scores indicate greater frequency of forgoing cigarettes.

    Time frame: Assessed 1 time, approximately 1 week after enrollment.

  5. Intentions to quit smoking

    Measured using 3 survey items (e.g., "How interested are you in quitting smoking cigarettes in the next 4 weeks?"). The 4-point response scale ranges from low intentions (coded as 1) to high intentions (coded as 4). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater intentions to quit smoking.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  6. Injunctive norms for quitting smoking

    Measured using 3 survey items (e.g., "People who are important to me think I should quit smoking."). The 5-point response scale ranges from "Strongly disagree" (coded as 1) to "Strongly agree" (coded as 5). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater injunctive norms for quitting smoking.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  7. Targeted benefits of quitting smoking

    Measured using 6 survey items (e.g., "If you were to stop smoking, how likely would you be to get more quality time with loved ones?"). The 5-point response scale ranges from "Not at all likely" (coded as 1) to "Extremely likely" (coded as 5). Researchers will average responses to the 7 survey items to create a scale score. Higher scores indicate greater targeted benefits of quitting smoking.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  8. Reactance towards cigarette options

    Measured using 3 survey items (e.g., "I was annoyed by the cigarette options in the Mini Mart."). The 5-point response scale ranges from "Strongly disagree" (coded as 1) to "Strongly agree" (coded as 5). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater reactance toward cigarette options.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  9. Reactance towards ads

    Measured using 3 survey items (e.g., "The ads annoyed me."). The 5-point response scale ranging from "Strongly disagree" (coded as 1) to "Strongly agree" (coded as 5). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater reactance toward ads.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  10. Stigma from cigarette options

    Measured using 1 survey item (i.e., "How much did the cigarette options in the Mini Mart make you feel judged by other people for smoking?"). The 5-point response scale ranges from "Not at all" (coded as 1) to "A great deal" (coded as 5) to create a scale score. Higher scores indicate greater stigma from cigarette options.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

  11. Stigma from ads

    Measured using 1 survey item (i.e., "How much did the ads make you feel judged by other people for smoking?"). The 5-point response scale ranges from "Not at all" (coded as 1) to "A great deal" (coded as 5). Higher scores indicate greater stigma from ads.

    Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

07

Study locations

1 of 1 sites recruiting
  • UNC Mini Mart
    Raleigh, North Carolina 27609, United States
    Recruiting
    • UNC Mini Mart Office UNC Mini Mart · Contactminimartstudy@unc.edu · 919-966-0233
    • Marissa Hall, PhD · Principal investigator
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Apr 2028, 24 months after the start.

Of 569 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 24 months is above that.

Counting every sponsor, half of 587 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2026
First posted
Mar 9, 2026
StartActual
Apr 20, 2026
Primary completionEst.
Apr 2028
CompletionEst.
Apr 2028
Last update
Apr 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07458607
Collaborators
National Institute on Drug Abuse (NIDA), Food and Drug Administration (FDA)
Responsible party
Sponsor
First posted
Mar 9, 2026
Start date
Apr 20, 2026
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Apr 27, 2026

Study contacts

Marissa G. Hall, PhD
study director · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion